Cytokinetics Inc. buy Morgan Stanley
Start price
04.08.23
/
50%
€30.20
Target price
04.08.24
€54.39
Performance (%)
67.22%
End price
05.08.24
€50.50
Summary
This prediction ended on 05.08.24 with a price of €50.50. With a performance of 67.22% the BUY prediction by Morgan_Stanley was a big success. Morgan_Stanley has a follow-up prediction for Cytokinetics Inc. where he still thinks Cytokinetics Inc. is a Buy. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Cytokinetics Inc. | -4.425% | -4.425% | 16.379% |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% |
Comments by Morgan_Stanley for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $60.00 price target on the stock.
Ratings data for CYTK provided by MarketBeat
In the thread Trading Cytokinetics Inc.
Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten